• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

链脲佐菌素诱导的非酒精性脂肪性肝炎小鼠经钆塞酸二钠增强磁共振成像后的自然病程:与单纯性脂肪肝小鼠的比较

The natural history of streptozotocin-stimulated non-alcoholic steatohepatitis mice followed by Gd-EOB-DTPA-enhanced MRI: Comparison with simple steatosis mice.

作者信息

Akai Hiroyuki, Kiryu Shigeru, Ohta Yasunori, Yasaka Koichiro, Nakano Yoshiyasu, Inoue Yusuke, Ohtomo Kuni

机构信息

Department of Radiology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.

Department of Radiology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.

出版信息

Magn Reson Imaging. 2017 May;38:123-128. doi: 10.1016/j.mri.2016.12.027. Epub 2017 Jan 3.

DOI:10.1016/j.mri.2016.12.027
PMID:28062263
Abstract

PURPOSE

To clarify the development of HCC, temporal change of steatosis and Gd-EOB-DTPA enhancement of non-alcoholic steatohepatitis (NASH) model mice by magnetic resonance imaging (MRI).

MATERIALS AND METHODS

All animal experiments were approved by the institution's Animal Research Committee. MRI was performed on six NASH and six simple steatosis (SS) model mice every 2weeks from the ages of 8weeks to 16weeks. The sequential changes in the number and size of the focal liver lesions detected on Gd-EOB-DTPA-enhanced MRI were evaluated. Additionally, the hepatic fat fraction (HFF), contrast-to-noise ratio (CNR) and relative enhancement (RE) were calculated at each time point. The temporal changes and correlations in these parameters were evaluated.

RESULTS

All alive NASH model mice demonstrated focal liver lesions from week 10, at the latest. Number of the lesions increased with time, and all the lesion enlarged with time. All the lesions larger than 1mm were confirmed as hepatocellular carcinoma (HCC) pathologically. While the HFF remained constant in NASH model mice, HFF in SS model mice dramatically increased with time. CNR of the NASH model mice remained constant through the study period, while CNR in SS model mice decreased with time. Although no correlation was seen in NASH model mice, the HFF showed a negative correlation against CNR and RE in SS model mice.

CONCLUSION

Development of HCC was observed using Gd-EOB-DTPA-enhanced MRI only in NASH model mice. Degree of steatosis and hepatic enhancement by Gd-EOB-DTPA was both constant in NASH model mice, while steatosis increased and hepatic enhancement decreased with time in SS model mice.

摘要

目的

通过磁共振成像(MRI)明确非酒精性脂肪性肝炎(NASH)模型小鼠肝癌(HCC)的发生发展、脂肪变性的时间变化以及钆塞酸二钠(Gd-EOB-DTPA)增强情况。

材料与方法

所有动物实验均经机构动物研究委员会批准。从8周龄至16周龄,每2周对6只NASH模型小鼠和6只单纯性脂肪变性(SS)模型小鼠进行MRI检查。评估钆塞酸二钠增强MRI检测到的局灶性肝损伤数量和大小的连续变化。此外,在每个时间点计算肝脏脂肪分数(HFF)、对比噪声比(CNR)和相对增强(RE)。评估这些参数的时间变化及相关性。

结果

所有存活的NASH模型小鼠最晚在第10周出现局灶性肝损伤。损伤数量随时间增加,所有损伤均随时间增大。所有直径大于1mm的损伤经病理证实为肝细胞癌(HCC)。NASH模型小鼠的HFF保持恒定,而SS模型小鼠的HFF随时间显著增加。NASH模型小鼠的CNR在研究期间保持恒定,而SS模型小鼠的CNR随时间下降。虽然在NASH模型小鼠中未观察到相关性,但在SS模型小鼠中HFF与CNR和RE呈负相关。

结论

仅在NASH模型小鼠中使用钆塞酸二钠增强MRI观察到了HCC的发生发展。NASH模型小鼠的脂肪变性程度和钆塞酸二钠增强的肝脏均保持恒定,而SS模型小鼠的脂肪变性随时间增加,肝脏增强随时间下降。

相似文献

1
The natural history of streptozotocin-stimulated non-alcoholic steatohepatitis mice followed by Gd-EOB-DTPA-enhanced MRI: Comparison with simple steatosis mice.链脲佐菌素诱导的非酒精性脂肪性肝炎小鼠经钆塞酸二钠增强磁共振成像后的自然病程:与单纯性脂肪肝小鼠的比较
Magn Reson Imaging. 2017 May;38:123-128. doi: 10.1016/j.mri.2016.12.027. Epub 2017 Jan 3.
2
Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice.钆塞酸二钠增强磁共振成像在小鼠非酒精性脂肪性肝炎(NASH)炎症期的应用
Magn Reson Imaging. 2016 Jul;34(6):724-729. doi: 10.1016/j.mri.2016.03.009. Epub 2016 Mar 12.
3
Correlation of histologic, imaging, and artificial intelligence features in NAFLD patients, derived from Gd-EOB-DTPA-enhanced MRI: a proof-of-concept study.基于钆塞酸二钠增强 MRI 的非酒精性脂肪性肝病患者的组织学、影像学和人工智能特征的相关性:一项概念验证研究。
Eur Radiol. 2023 Nov;33(11):7729-7743. doi: 10.1007/s00330-023-09735-5. Epub 2023 Jun 26.
4
Evaluation of hepatic function using dynamic contrast-enhanced magnetic resonance imaging in melanocortin 4 receptor-deficient mice as a model of nonalcoholic steatohepatitis.使用动态对比增强磁共振成像评估黑素皮质素4受体缺陷小鼠作为非酒精性脂肪性肝炎模型的肝功能。
Magn Reson Imaging. 2019 Apr;57:210-217. doi: 10.1016/j.mri.2018.11.013. Epub 2018 Nov 19.
5
Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.在肝胆期磁共振成像延迟相,肝细胞癌转基因小鼠模型中,钆塞酸二钠(Gd-EOB-DTPA)与钆喷替酸葡甲胺(Gd-DTPA)增强 MRI 的信号强度不同。
J Magn Reson Imaging. 2012 Jun;35(6):1397-402. doi: 10.1002/jmri.23584. Epub 2012 Jan 20.
6
Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging.钆-乙氧基苄基-二乙烯三胺五乙酸(Gd-EOB-DTPA)利用磁共振成像对大鼠非酒精性脂肪性肝炎和脂肪肝进行鉴别诊断的潜力。
Invest Radiol. 2007 Apr;42(4):242-7. doi: 10.1097/01.rli.0000258058.44876.a5.
7
Unenhanced fat fraction ratios obtained by MR and enhanced T2* values with liver-specific MR contrast agents for diagnosis of non-alcoholic steatohepatitis in rats.通过磁共振成像(MR)获得的未增强脂肪分数比值以及使用肝脏特异性MR造影剂的增强T2*值用于大鼠非酒精性脂肪性肝炎的诊断。
Acta Radiol. 2011 Jul 1;52(6):658-64. doi: 10.1258/ar.2011.100360. Epub 2011 Apr 6.
8
Usefulness of Gd-EOB-DTPA-enhanced MR imaging in the evaluation of simple steatosis and nonalcoholic steatohepatitis.钆塞酸二钠增强 MRI 在单纯性脂肪变性和非酒精性脂肪性肝炎评估中的作用。
J Magn Reson Imaging. 2013 May;37(5):1137-43. doi: 10.1002/jmri.23921. Epub 2012 Nov 21.
9
Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.检测和描述肝脏局灶性病变:一项日本 III 期、多中心的钆塞酸二钠增强磁共振成像与增强计算机断层扫描对比研究,主要针对肝细胞癌和慢性肝病患者。
Invest Radiol. 2010 Mar;45(3):133-41. doi: 10.1097/RLI.0b013e3181caea5b.
10
Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI.肝细胞癌在对比增强计算机断层扫描、钆喷酸葡胺增强磁共振成像和钆塞酸二钠增强磁共振成像上的个体内影像特征比较
Acta Radiol. 2018 Jun;59(6):639-648. doi: 10.1177/0284185117728534. Epub 2017 Aug 20.

引用本文的文献

1
Noninvasive prediction of insufficient biochemical response after ursodeoxycholic acid treatment in patients with primary biliary cholangitis based on pretreatment nonenhanced MRI.基于治疗前非增强 MRI,预测原发性胆汁性胆管炎患者熊去氧胆酸治疗后生化应答不足。
Eur Radiol. 2024 Feb;34(2):1268-1279. doi: 10.1007/s00330-023-10080-w. Epub 2023 Aug 15.
2
Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides.实验模型中 NAFLD 和 NASH 的病理生理学:摄食调节肽的作用。
Front Endocrinol (Lausanne). 2020 Nov 26;11:597583. doi: 10.3389/fendo.2020.597583. eCollection 2020.
3
The inhibitory effect of gadoxetate disodium on hepatic transporters: a study using indocyanine green.
钆塞酸二钠对肝转运体的抑制作用:使用吲哚菁绿的研究。
Eur Radiol. 2018 Oct;28(10):4128-4133. doi: 10.1007/s00330-018-5403-5. Epub 2018 Apr 12.